MENU
+Compare
GERN
Stock ticker: NASDAQ
AS OF
Dec 18, 04:59 PM (EDT)
Price
$3.77
Change
-$0.15 (-3.82%)
Capitalization
2.38B

GERN Geron Corp Forecast, Technical & Fundamental Analysis

a developer of therapeutic products for cancer

Industry Biotechnology
GERN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
a Summary for GERN with price predictions
Dec 17, 2024

Momentum Indicator for GERN turns negative, indicating new downward trend

GERN saw its Momentum Indicator move below the 0 level on December 05, 2024. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 100 similar instances where the indicator turned negative. In of the 100 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for GERN turned negative on December 13, 2024. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where GERN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where GERN's RSI Indicator exited the oversold zone, of 23 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 66 cases where GERN's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where GERN advanced for three days, in of 220 cases, the price rose further within the following month. The odds of a continued upward trend are .

GERN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. GERN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to slightly better than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.794) is normal, around the industry mean (14.664). P/E Ratio (0.000) is within average values for comparable stocks, (87.689). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.783). GERN has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.012). P/S Ratio (80.645) is also within normal values, averaging (260.687).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

View a ticker or compare two or three
GERN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

GERN is expected to report earnings to fall 17.75% to -3 cents per share on March 06

Geron Corp GERN Stock Earnings Reports
Q4'24
Est.
$-0.03
Q3'24
Beat
by $0.04
Q2'24
Est.
$-0.10
Q1'24
Beat
by $0.03
Q4'23
Beat
by $0.02
The last earnings report on November 07 showed earnings per share of -3 cents, beating the estimate of -7 cents. With 7.67M shares outstanding, the current market capitalization sits at 2.38B.
A.I. Advisor
published General Information

General Information

a developer of therapeutic products for cancer

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
919 East Hillsdale Boulevard
Phone
+1 650 473-7700
Employees
141
Web
https://www.geron.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FARCX15.61-0.06
-0.38%
Nuveen Real Estate Securities I
FRESX41.13-0.19
-0.46%
Fidelity Real Estate Investment Port
VFWPX124.28-0.61
-0.49%
Vanguard FTSE All-Wld ex-US Idx Ins Plus
MOWNX16.36-0.14
-0.85%
Moerus Worldwide Value N
PPQMX10.90-0.10
-0.91%
Principal MidCap Growth III R3

GERN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, GERN has been closely correlated with SER. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if GERN jumps, then SER could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GERN
1D Price
Change %
GERN100%
+3.15%
SER - GERN
67%
Closely correlated
+15.42%
LIANY - GERN
53%
Loosely correlated
+4.24%
VCYT - GERN
44%
Loosely correlated
-2.52%
MIRM - GERN
39%
Loosely correlated
+0.61%
NRIX - GERN
37%
Loosely correlated
+1.78%
More

Groups containing GERN

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GERN
1D Price
Change %
GERN100%
+3.15%
GERN
(2 stocks)
77%
Closely correlated
+12.02%